Gene · 6548
Papers3,457
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,457
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting hypoxia regulated sodium driven bicarbonate transporters reduces triple negative breast cancer metastasis. | Neoplasia | 2022 | 35150959 | PubTator, text mining | PubMed |
| Mitochondria as Therapeutic Targets in Heart Failure. | Curr Heart Fail Rep | 2022 | 35147851 | PubTator, text mining | PubMed |
| Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin. | Elife | 2022 | 35147495 | PubTator, text mining | PubMed |
| Colorectal cancer extracellular acidosis decreases immune cell killing and is partially ameliorated by pH-modulating agents that modify tumor cell cytokine profiles. | Am J Cancer Res | 2022 | 35141009 | PubTator, text mining | PubMed |
| Oxidized alkyl phospholipids stimulate sodium transport in proximal tubules via a nongenomic PPARγ-dependent pathway. | J Biol Chem | 2022 | 35124009 | PubTator, text mining | PubMed |
| ROCK1 mechano-signaling dependency of human malignancies driven by TEAD/YAP activation. | Nat Commun | 2022 | 35121738 | PubTator, text mining | PubMed |
| Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis. | Nat Commun | 2022 | 35102146 | PubTator, text mining | PubMed |
| Permissive role of Na+/H+ exchanger isoform 1 in migration and invasion of triple-negative basal-like breast cancer cells. | Mol Cell Biochem | 2022 | 35084672 | PubTator, text mining | PubMed |
| Sensitive asprosin detection in clinical samples reveals serum/saliva correlation and indicates cartilage as source for serum asprosin. | Sci Rep | 2022 | 35079041 | PubTator, text mining | PubMed |
| A non-catalytic herpesviral protein reconfigures ERK-RSK signaling by targeting kinase docking systems in the host. | Nat Commun | 2022 | 35078976 | PubTator, text mining | PubMed |
| miR-200a/b/-429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer. | Mol Oncol | 2022 | 35064630 | PubTator, text mining | PubMed |
| An ex vivo system to study cellular dynamics underlying mouse peri-implantation development. | Dev Cell | 2022 | 35063082 | PubTator, text mining | PubMed |
| Antioxidant Roles of SGLT2 Inhibitors in the Kidney. | Biomolecules | 2022 | 35053290 | PubTator, text mining | PubMed |
Integration of gene co-expression analysis and multi-class SVM specifies the functional players involved in determining the fate of HTLV-1 infection toward the development of cancer (ATLL) or neurological disorder (HAM/TSP). | PLoS One | 2022 | 35041720 | PubTator, text mining | PubMed |
| Core promoter mutation contributes to abnormal gene expression in bladder cancer. | BMC Cancer | 2022 | 35033028 | PubTator, text mining | PubMed |
| Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions. | J Evid Based Integr Med | 2022 | 35018864 | PubTator, text mining | PubMed |
| A Protein Composite Neural Scaffold Modulates Astrocyte Migration and Transcriptome Profile. | Macromol Biosci | 2022 | 35014754 | PubTator, text mining | PubMed |
| Real time imaging of single extracellular vesicle pH regulation in a microfluidic cross-flow filtration platform. | Commun Biol | 2022 | 35013561 | PubTator, text mining | PubMed |
| The catalytic activity of TCPTP is auto-regulated by its intrinsically disordered tail and activated by Integrin alpha-1. | Nat Commun | 2022 | 35013194 | PubTator, text mining | PubMed |
| High cell surface expression and peptide binding affinity of HLA-DQA1*05:03, a susceptible allele of neuromyelitis optica spectrum disorders (NMOSD). | Sci Rep | 2022 | 34997058 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6548/papers?page=33